Graham Capital Management, L.P. Apellis Pharmaceuticals, Inc. Transaction History
Graham Capital Management, L.P.
- $3.11 Billion
- Q2 2024
A detailed history of Graham Capital Management, L.P. transactions in Apellis Pharmaceuticals, Inc. stock. As of the latest transaction made, Graham Capital Management, L.P. holds 5,237 shares of APLS stock, worth $186,070. This represents 0.01% of its overall portfolio holdings.
Number of Shares
5,237
Previous 6,742
22.32%
Holding current value
$186,070
Previous $396,000
49.49%
% of portfolio
0.01%
Previous 0.01%
Shares
4 transactions
Others Institutions Holding APLS
# of Institutions
299Shares Held
113MCall Options Held
5.21MPut Options Held
691K-
Wellington Management Group LLP Boston, MA16.4MShares$582 Million0.11% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA11.6MShares$412 Million15.74% of portfolio
-
Avoro Capital Advisors LLC New York, NY11.1MShares$395 Million5.82% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.81MShares$349 Million0.01% of portfolio
-
Black Rock Inc. New York, NY5.8MShares$206 Million0.01% of portfolio
About Apellis Pharmaceuticals, Inc.
- Ticker APLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 109,865,000
- Market Cap $3.9B
- Description
- Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...